Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 21;12(1):52.
doi: 10.1186/s13643-023-02197-2.

The impact of rate and rhythm control strategies on quality of life for patients with atrial fibrillation: a protocol for a systematic review

Powsiga Uruthirakumar  1 , Rajendra Surenthirakumaran  2 , Tiffany E Gooden  3 , Gregory Y H Lip  4   5   6 , G Neil Thomas  3 , David J Moore  3 , Krishnarajah Nirantharakumar  3 , Balachandran Kumarendran  1 , Kumaran Subaschandran  1 , Shribavan Kaneshamoorthy  1 , Vethanayagam Antony Sheron  1 , Mahesan Guruparan  7 ; NIHR Global Health Research Group on Atrial Fibrillation Management
Collaborators, Affiliations

The impact of rate and rhythm control strategies on quality of life for patients with atrial fibrillation: a protocol for a systematic review

Powsiga Uruthirakumar et al. Syst Rev. .

Erratum in

Abstract

Background: Atrial fibrillation (AF) is the most common heart arrhythmia globally and it adversely affects the quality of life (QoL). Available rate and rhythm control strategies equally reduce mortality but may impact QoL differently. A number of systematic reviews have focused on the impact of specific strategies on QoL, though a 2006 review synthesized the evidence on the effect of all strategies on QoL, allowing for a clinically important comparison between the types of strategies. Many trials have been published since the review undertook the search in 2005; therefore, an update is needed. This systematic review aims to provide an update to the 2006 review on the impact of all rate and rhythm control strategies on QoL in people with AF.

Methods: The following four databases and three clinical trial registries will be searched for primary studies: CENTRAL, MEDLINE, Embase, CINAHL, WHO International Clinical Trials Registry Platform, ClinicalTrials.gov, and ClinicalTrialsRegister.eu. No language restriction will be applied. The search will be limited to 2004 or later publication year to allow overlap with the search conducted by the 2006 review authors. Any randomized control trial that reports the QoL of adult (≥ 18 years) AF patients following an eligible rate or rhythm control intervention will be eligible for inclusion. Eligible interventions (and comparators) include pacing, atrioventricular node junction and bundle of HIS ablation, pharmacological therapy, radio frequency catheter ablation, cryoablation, pulmonary vein isolation, maze operation, pace maker implantation, and defibrillator implantation. Two reviewers will independently screen for eligible studies, extract the data using a piloted tool, and assess bias by QoL outcome using the RoB 2 tool. The suitability of conducting a meta-analysis will be assessed by the clinical and methodology similarities of included studies. If it is feasible, standardized mean differences will be pooled using a random-effects model and assessed appropriately.

Discussion: The findings from this review will allow for meaningful comparisons between various rate and rhythm control strategies regarding their impact on QoL. This review will be useful for a wide range of stakeholders and will be crucial for optimizing the overall wellbeing of AF patients.

Systematic review registration: PROSPERO CRD42021290542.

Keywords: Atrial fibrillation; Protocol; Quality of life; Rate control; Rhythm control; Systematic review.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Morillo CA, Banerjee A, Perel P, Wood D, Jouven X. Atrial fibrillation: the current epidemic. J Geriatr Cardiol. 2017;14(3):195–203. - PMC - PubMed
    1. Allan KS, Aves T, Henry S, Banfield L, Victor JC, Dorian P, et al. Health-related quality of life in patients with atrial fibrillation treated with catheter ablation or antiarrhythmic drug therapy: a systematic review and meta-analysis. CJC Open. 2020;2(4):286–295. doi: 10.1016/j.cjco.2020.03.013. - DOI - PMC - PubMed
    1. Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. Atrial fibrillation: epidemiology, pathophysiology, clinical outcomes. Circ Res. 2017;120(9):1501–1517. doi: 10.1161/CIRCRESAHA.117.309732. - DOI - PMC - PubMed
    1. Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217–221. doi: 10.1177/1747493019897870. - DOI - PubMed
    1. Zhang L, Gallagher R, Lowres N, Orchard J, Freedman SB, Neubeck L. Using the ‘Think Aloud’ technique to explore quality of life issues during standard quality-of-life questionnaires in patients with atrial fibrillation. Heart Lung Circ. 2017;26(2):150–6. doi: 10.1016/j.hlc.2016.05.121. - DOI - PubMed

Publication types